期刊
NEUROLOGY
卷 97, 期 9, 页码 423-433出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000012466
关键词
-
资金
- National Natural Science Foundation of China [U190420029, 91849115, 81530037, 81771290, 81974211, 81901300]
- National Key Research and Development Program of China [2017YFA0105003]
- Scientific and Technological Project of Henan Province [SBGJ202003020]
Emerging long-read single-molecule DNA sequencing technologies provide unprecedented resolutions for studying genomes, transcriptomes, and metagenomes, thus expanding our understanding of unresolved issues in neurodegenerative diseases.
Neurodegenerative diseases exhibit chronic progressive lesions in the central and peripheral nervous systems with unclear causes. The search for pathogenic mutations in human neurodegenerative diseases has benefited from massively parallel short-read sequencers. However, genomic regions, including repetitive elements, especially with high/low GC content, are far beyond the capability of conventional approaches. Recently, long-read single-molecule DNA sequencing technologies have emerged and enabled researchers to study genomes, transcriptomes, and metagenomes at unprecedented resolutions. The identification of novel mutations in unresolved neurodegenerative disorders, the characterization of causative repeat expansions, and the direct detection of epigenetic modifications on naive DNA by virtue of long-read sequencers will further expand our understanding of neurodegenerative diseases. In this article, we review and compare 2 prevailing long-read sequencing technologies, Pacific Biosciences and Oxford Nanopore Technologies, and discuss their applications in neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据